Simon Drysdale

Midwive take part in City St George’s, University of London EQUIP Study, which aims to improve knowledge, practice around maternal vaccination. Participation involves completing two online questionnaires, using study materials, the opportunity to win a £100 voucher.

RSV jab in pregnancy can ‘significantly’ cut baby’s infection risk, study says | The Independent independent.co.uk/life-style/hea…

Premature babies in UK to be immunised against winter virus RSV - BBC News bbc.co.uk/news/articles/…

🦠 Thread: RSV Vaccine Effectiveness in Older Adults (Oct 2023 - Mar 2024) 🧵

🧵✨ New study alert: “Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children” 🚸💉Let’s have a look….

🦠💉 New RSV Study Alert! Our (@RESCEUproject) recent research explores how antibodies protect against #RSV in older adults and identifies asymptomatic RSV infections in European communities. Let’s break it down! 🧵👇

💉🦠 Breaking News in RSV Prevention! Our new article in @ArchivesEandP highlights advances in preventing #RSV disease through immunisation. Let's explore how vaccines and monoclonal antibodies are protecting our little ones & older adults! 🧵👇

Well, this is depressing recent data from NHSE / UKHSA. Not surprising we’re having outbreaks of measles and pertussis in London & elsewhere….#VaccinesWork

app.powerbi.com/view?r=eyJrIjo…

healthpublications.gov.uk/ViewArticle.ht…

digital.nhs.uk/data-and-infor…

🧵 Let's dive into “What have we learned from animal studies of immune responses to respiratory syncytial virus (RSV) infection? 🦠🐭🐮 in our new paper out now.
@RESCEUproject @p_openshaw @ajpollard1

🧵 THREAD: The Major Public Health Impact of RSV on U.S. Adults

1/ 🦠 A new study reveals the alarming burden of Respiratory Syncytial Virus (RSV) in U.S. adults, often overlooked compared to other respiratory diseases.

🧵 Understanding Parental Perspectives on RSV Immunization in Spain
1/ 🦠 RSV is a leading cause of severe respiratory infections in infants. Before Murcia’s nirsevimab immunization program, researchers examined how much parents knew about RSV and attitudes toward vaccination.

🧵 New Study on RSV Immunization

1/🚨Respiratory syncytial virus (RSV) is a major threat to infants, causing severe respiratory infections. In response, Murcia in Spain launched its first immunization campaign using nirsevimab, a monoclonal antibody designed to protect newborns.

🧵 Our recent systematic review and meta-analysis published in @LancetGH examines the impact of mpox (formerly monkeypox) on children, pregnant women, and congenital cases. Here’s what you need to know:

Disseminated Coccidioidomycosis | New England Journal of Medicine nejm.org/doi/full/10.10…

Our new paper on Gp A Strep parapneumonic effusions in children. Fever for 12 days, Abx for 14 days & lots of broad spectrum Abx use despite limited evidence for 2ry infections.
@PIDJournal @OxPaediatrics

Our latest paper out now:
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with #RSV ⁦@NatureComms⁩ ⁦@RESCEUproject⁩ nature.com/articles/s4146…

Special thank you to my 11 new followers from Belgium, and more last week. fedica.com/!sbdrysdale

Our new paper: “Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis” @LancetGH

-61 studies, 53 reported paediatric outcomes (n=2123 cases)
-Pooled paediatric case fatality ratio was 11% (95% CI 4–20)

Article available at:
authors.elsevier.com/sd/article/S22…

More real-world data showing Nirsevimab is well accepted and efficacious!
It was >70% effective in preventing RSV LRTI hospitalisation in infants in 3 Spanish regions, where a universal immunisation programme began in late September 2023 (coverage:79–99%).
pubmed.ncbi.nlm.nih.gov/38333937/

🔥Out at last!🔥

Immunomodulatory therapy in children with PIMS-TS / MIS-C from RECOVERY Collaborative group @LancetChildAdol
#Steroids #Tocilizumab

pubmed.ncbi.nlm.nih.gov/38272046/